These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603. Kanemitsu Y, Kato T, Shimizu Y, Inaba Y, Shimada Y, Nakamura K, Sato A, Moriya Y, Colorectal Cancer Study Group (CCSG) of Japan Clinical Oncology Group. Jpn J Clin Oncol; 2009 Jun; 39(6):406-9. PubMed ID: 19389795 [Abstract] [Full Text] [Related]
4. Sorafenib in combination with oxaliplatin, leucovorin, and fluorouracil (modified FOLFOX6) as first-line treatment of metastatic colorectal cancer: the RESPECT trial. Tabernero J, Garcia-Carbonero R, Cassidy J, Sobrero A, Van Cutsem E, Köhne CH, Tejpar S, Gladkov O, Davidenko I, Salazar R, Vladimirova L, Cheporov S, Burdaeva O, Rivera F, Samuel L, Bulavina I, Potter V, Chang YL, Lokker NA, O'Dwyer PJ. Clin Cancer Res; 2013 May 01; 19(9):2541-50. PubMed ID: 23532888 [Abstract] [Full Text] [Related]
8. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival. Yasuno M, Uetake H, Ishiguro M, Mizunuma N, Komori T, Miyata G, Shiomi A, Kagimura T, Sugihara K. Int J Clin Oncol; 2019 May 01; 24(5):516-525. PubMed ID: 30612267 [Abstract] [Full Text] [Related]
9. Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients. Machida N, Yoshizaki K, Boku N, Yamazaki K, Onozawa Y, Fukutomi A, Yasui H, Taku K. Int J Clin Oncol; 2013 Apr 01; 18(2):279-84. PubMed ID: 22367535 [Abstract] [Full Text] [Related]
14. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study. Taïeb J, Artru P, Paye F, Louvet C, Perez N, André T, Gayet B, Hebbar M, Goebel FM, Tournigand C, Parc R, de Gramont A. J Clin Oncol; 2005 Jan 20; 23(3):502-9. PubMed ID: 15659495 [Abstract] [Full Text] [Related]
15. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S. J Clin Oncol; 2004 Dec 01; 22(23):4753-61. PubMed ID: 15570076 [Abstract] [Full Text] [Related]
18. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M. Ann Surg Oncol; 2008 Jan 01; 15(1):219-26. PubMed ID: 17896145 [Abstract] [Full Text] [Related]
20. [The clinical outcome of mFOLFOX6 treatment for colorectal cancer patients who underwent resection of liver metastasis -comparison between synchronous and metachronous liver metastasis]. Honjou H, Ishibashi K, Okada N, Tajima Y, Ishiguro T, Kuwabara K, Ohsawa T, Kumamoto K, Tsuji Y, Haga N, Iwama T, Ishida H. Gan To Kagaku Ryoho; 2011 Nov 01; 38(12):2216-9. PubMed ID: 22202335 [Abstract] [Full Text] [Related] Page: [Next] [New Search]